ArticleJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2026
Electroacupuncture alleviates intestinal inflammation in rats with ulcerative colitis by regulating colonic cell autophagy and gut microbiota.
Article in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo investigate the effects of electroacupuncture (EA) on autophagy and gut microbiota homeostasis in a dextran sulfate sodium (DSS)-induced rat model of ulcerative colitis (UC).
methodsUC rats received EA treatment, and efficacy was evaluated by disease activity index (DAI), colon length, serum cytokines, and histopathology. Autophagy was assessed by transmission electron microscopy (TEM), reverse transcription quantitative polymerase chain reaction, and Western blotting for autophagy-related protein (ATG)5, ATG12, microtubule-associated protein 1 light chain 3 (LC3), and sequestosome 1 (p62), with phosphatidylinositol 3-kinase/protein kinase B/ mammalian target of rapamycin (PI3K/AKT/mTOR) pathway analysis. Gut microbiota composition was profiled by 16S ribosomal RNA (rRNA) gene sequencing, and functional relevance was confirmed by fecal microbiota transplantation (FMT).
resultsEA reduced DAI scores, preserved colon length, lowered tumor necrosis factor-α and interleukin-1β (IL-1β), and elevated IL-2 and IL-10. Colonic injury and inflammatory infiltration were alleviated, autophagy markers improved, and PI3K/AKT/mTOR pathway activity was suppressed. EA also enhanced microbiota diversity and composition, with FMT confirming its microbiota-autophagy-inflammation modulatory role.
conclusionEA alleviates UC by promoting colonic epithelial autophagy through PI3K/AKT/mTOR pathway inhibition and restoring gut microbiota balance, offering a promising therapeutic strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.